Rate My Professor Anna Finnane

Finnane's research specializations encompass teledermatology applications for skin cancer diagnosis, efficacy of smartphone applications for high-risk pigmented lesions, and innovative technologies like 3D total-body photography for melanoma surveillance in high-risk patients. Key publications include the 2025 randomized clinical trial '3D Total-Body Photography in Patients at High Risk for Melanoma' in JAMA Dermatology, demonstrating benefits over usual care; the accompanying 'Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma' (2025); 'Protocol to evaluate a pilot program to upskill clinicians in providing genetic testing for familial melanoma' (2022, PLOS ONE); 'Teledermatology for the Diagnosis and Management of Skin Cancer' (2017, JAMA Dermatology); and 'Cost-effectiveness of Store-and-Forward Teledermatology: A Systematic Review' (2016, JAMA Dermatology). She has also examined the growth of skin emergency teledermatology services from 2008 to 2015 and real-time teledermatology clinics. Supporting the Store and Forward research stream in the Centre of Research Excellence in Telehealth, her work has garnered over 1,230 citations, influencing clinical adoption of remote dermatology and early detection strategies. Finnane contributed to public awareness with a 2014 article in The Conversation titled 'Spot the difference: harmless mole or potential skin cancer?' Her ongoing efforts in the School of Public Health continue to bridge public health and dermatological innovation.